Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
2000 1
2001 1
2013 2
2014 3
2015 4
2016 4
2017 2
2018 8
2019 5
2020 3
2021 1
2022 3
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Telomerase-targeted therapies in myeloid malignancies.
Waksal JA, Bruedigam C, Komrokji RS, Jamieson CHM, Mascarenhas JO. Waksal JA, et al. Among authors: mascarenhas jo. Blood Adv. 2023 Aug 22;7(16):4302-4314. doi: 10.1182/bloodadvances.2023009903. Blood Adv. 2023. PMID: 37216228 Free PMC article. Review.
Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity.
Adegbite BO, Abramson MH, Gutgarts V, Musteata FM, Chauhan K, Muwonge AN, Meliambro KA, Salvatore SP, El Ghaity-Beckley S, Kremyanskaya M, Marcellino B, Mascarenhas JO, Campbell KN, Chan L, Coca SG, Berman EM, Jaimes EA, Azeloglu EU. Adegbite BO, et al. Among authors: mascarenhas jo. Clin J Am Soc Nephrol. 2023 Sep 1;18(9):1175-1185. doi: 10.2215/CJN.0000000000000219. Epub 2023 Jun 29. Clin J Am Soc Nephrol. 2023. PMID: 37382967
Novel therapeutics and targets in myelofibrosis.
Waksal JA, Harrison CN, Mascarenhas JO. Waksal JA, et al. Among authors: mascarenhas jo. Leuk Lymphoma. 2022 May;63(5):1020-1033. doi: 10.1080/10428194.2021.2010068. Epub 2021 Dec 2. Leuk Lymphoma. 2022. PMID: 34852713 Review.
Dasatinib nephrotoxicity correlates with patient-specific pharmacokinetics.
Adegbite BO, Abramson MH, Gutgarts V, Musteata MF, Chauhan K, Muwonge AN, Meliambro KA, Salvatore SP, Ghaity-Beckley SE, Kremyanskaya M, Marcellino B, Mascarenhas JO, Campbell KN, Chan L, Coca SG, Berman EM, Jaimes EA, Azeloglu EU. Adegbite BO, et al. Among authors: mascarenhas jo. medRxiv [Preprint]. 2023 Apr 17:2023.04.09.23288333. doi: 10.1101/2023.04.09.23288333. medRxiv. 2023. PMID: 37131844 Free PMC article. Updated. Preprint.
41 results